ANIX · Anixa Biosciences Inc
$3.71
-0.05 (-1.20%)
At close · Jul 24
Market Cap
$125.89M
Shares
34.02M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $2,546,684 |
| Michael J. Catelani | CFO | $1,298,705 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $3,476,037 |
| Michael J. Catelani | CFO | $1,760,002 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $3,639,651 |
| Michael J. Catelani | CFO | $1,965,876 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $2,159,033 |
| Michael J. Catelani | CFO | $1,848,558 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $10,959,086 |
| Michael J. Catelani | CFO | $1,282,348 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $2,395,265 |
| Michael J. Catelani | CFO | $659,219 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Dr. Amit Kumar | CEO | $665,490 |
| Michael J. Catelani | CFO | $313,021 |